Immunosav ZnD3

IMMUNOSAV ZND3

Zinc supplementation can be a useful strategy to reduce the global burden of infection in the elderly, there is a need the increased reporting to improve our understanding of COVID-19 and the care of affected patients.

COVIT-TRIAL is to our knowledge the first randomized controlled trial testing the effect of vitamin D supplementation on the prognosis of COVID-19 in high-risk older patients. High-dose vitamin D supplementation may be an effective, well-tolerated, and easily and immediately accessible treatment for COVID-19, the incidence of which increases dramatically and for which there are currently no scientifically validated treatments.

COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial. Cédric Annweiler 1 2 3, Mélinda Beaudenon 4, Jennifer Gautier 4, Romain Simon 4, Vincent Dubée 5 6, Justine Gonsard 7, Elsa Parot-Schinkel 7 8, COVIT-TRIAL study group.

Vitamin C:

• Contributes to maintain the normal function of the immune system during and after intensal physical exercise;
• Contributes to the normal function of the immune system;
• Contributes to normal psychological function;
• Contributes to the protections of cells from oxidative stress;
• Contributes to the reduction of tiredness and fatigue.